Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HUMALOG LISPRO vs HUMAN C1-ESTERASE INHIBITOR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

HUMALOG LISPRO vs HUMAN C1-ESTERASE INHIBITOR: Safety Overview

Metric HUMALOG LISPRO HUMAN C1-ESTERASE INHIBITOR
Total FAERS Reports 435 14,344
Deaths Reported 13 1,403
Death Rate 3.0% 9.8%
Hospitalizations 227 3,966
Average Patient Age 54.6 yrs 42.7 yrs
% Female Patients N/A 79.1%
Manufacturer N/A Takeda Pharmaceuticals America, Inc.